Publication:
IL8 and IL16 levels indicate serum and plasma quality.

dc.contributor.authorKofanova, Olga
dc.contributor.authorHenry, Estelle
dc.contributor.authorAguilar Quesada, Rocio
dc.contributor.authorBulla, Alexandre
dc.contributor.authorNavarro Linares, Hector
dc.contributor.authorLescuyer, Pierre
dc.contributor.authorShea, Kathi
dc.contributor.authorStone, Mars
dc.contributor.authorTybring, Gunnel
dc.contributor.authorBellora, Camille
dc.contributor.authorBetsou, Fay
dc.date.accessioned2023-01-25T10:03:34Z
dc.date.available2023-01-25T10:03:34Z
dc.date.issued2018
dc.description.abstractLonger pre-centrifugation times alter the quality of serum and plasma samples. Markers for such delays in sample processing and hence for the sample quality, have been identified. Twenty cytokines in serum, EDTA plasma and citrate plasma samples were screened for changes in concentration induced by extended blood pre-centrifugation delays at room temperature. The two cytokines that showed the largest changes were further validated for their "diagnostic performance" in identifying serum or plasma samples with extended pre-centrifugation times. In this study, using R&D Systems ELISA kits, EDTA plasma samples and serum samples with a pre-centrifugation delay longer than 24 h had an IL16 concentration higher than 313 pg/mL, and an IL8 concentration higher than 125 pg/mL, respectively. EDTA plasma samples with a pre-centrifugation delay longer than 48 h had an IL16 concentration higher than 897 pg/mL, citrate plasma samples had an IL8 concentration higher than 21.5 pg/mL and serum samples had an IL8 concentration higher than 528 pg/mL. These robust and accurate tools, based on simple and commercially available ELISA assays can greatly facilitate qualification of serum and plasma legacy collections with undocumented pre-analytics.
dc.identifier.doi10.1515/cclm-2017-1047
dc.identifier.essn1437-4331
dc.identifier.pmid29425105
dc.identifier.unpaywallURLhttps://archive-ouverte.unige.ch/unige:102397/ATTACHMENT01
dc.identifier.urihttp://hdl.handle.net/10668/12108
dc.issue.number7
dc.journal.titleClinical chemistry and laboratory medicine
dc.journal.titleabbreviationClin Chem Lab Med
dc.language.isoen
dc.organizationBiobanco del Sistema Sanitario Público de Andalucía
dc.page.number1054-1062
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectinterleukin
dc.subjectplasma
dc.subjectpreanalytical
dc.subjectquality control
dc.subjectserum
dc.subject.meshAdult
dc.subject.meshArthritis, Rheumatoid
dc.subject.meshBiomarkers
dc.subject.meshBlood Chemical Analysis
dc.subject.meshCentrifugation
dc.subject.meshCohort Studies
dc.subject.meshEnzyme-Linked Immunosorbent Assay
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInterleukin-16
dc.subject.meshInterleukin-8
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPancreatitis
dc.subject.meshROC Curve
dc.subject.meshSpecimen Handling
dc.subject.meshTemperature
dc.subject.meshTime Factors
dc.subject.meshYoung Adult
dc.titleIL8 and IL16 levels indicate serum and plasma quality.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number56
dspace.entity.typePublication

Files